Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Joint stock

JYNT
US47973J1025
A12FCC

Price

11.39
Today +/-
-0.01
Today %
-0.09 %

Joint stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Joint stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Joint stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Joint stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Joint's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Joint Stock Price History

DateJoint Price
2/6/202511.39 undefined
2/5/202511.40 undefined
2/4/202511.44 undefined
2/3/202511.42 undefined
2/2/202511.39 undefined
1/30/202511.05 undefined
1/29/202511.34 undefined
1/28/202511.25 undefined
1/27/202511.29 undefined
1/26/202511.13 undefined
1/23/202511.29 undefined
1/22/202511.05 undefined
1/21/202511.11 undefined
1/20/202511.40 undefined
1/16/202511.19 undefined
1/15/202511.00 undefined
1/14/202510.26 undefined
1/13/202510.22 undefined
1/12/202510.33 undefined

Joint Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Joint, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Joint from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Joint’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Joint. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Joint’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Joint’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Joint’s growth potential.

Joint Revenue, EBIT and net profit per share

DateJoint RevenueJoint EBITJoint Net Income
2026e88.82 M undefined12.6 M undefined9.17 M undefined
2025e105.69 M undefined5.89 M undefined4.55 M undefined
2024e121.56 M undefined-5.35 M undefined-5.71 M undefined
2023117.7 M undefined559,520 undefined-9.75 M undefined
2022101.3 M undefined1.2 M undefined600,000 undefined
202180 M undefined6.1 M undefined7.6 M undefined
202058.7 M undefined5.4 M undefined13.2 M undefined
201948.5 M undefined3.5 M undefined3.3 M undefined
201836.7 M undefined800,000 undefined100,000 undefined
201724.9 M undefined-2.9 M undefined-3.4 M undefined
201620.5 M undefined-11.5 M undefined-15.2 M undefined
201513.8 M undefined-9.4 M undefined-8.8 M undefined
20147.1 M undefined-1.6 M undefined-3 M undefined
20136 M undefined400,000 undefined200,000 undefined
20122.8 M undefined-1.3 M undefined-700,000 undefined

Joint Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e
2671320243648588010111712110588
-200.0016.6785.7153.8520.0050.0033.3320.8337.9326.2515.843.42-13.22-16.19
50.0066.6757.1484.6285.0087.5088.8987.5089.6690.0091.0991.4588.43101.90121.59
1441117213242527292107000
00-3-8-15-3031370-9-549
---166.6787.50-80.00--333.33-46.15---44.44-180.00125.00
9.29.25.51012.713.21414.514.614.914.914.69000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The Joint Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Joint is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201220132014201520162017201820192020202120222023
                       
3.573.5220.816.793.014.228.728.4620.5519.539.7518.15
0.110.390.70.741.021.140.812.652.063.73.913.72
1030430140801701501200000
000000000000
2.41.721.231.361.581.141.632.072.733.663.9622.46
6.095.6623.1619.035.696.6711.3113.325.3426.8917.6244.34
0.230.41.137.144.723.83.6619.0720.3332.8138.0623.46
000000000000
100803020035013000000
000.152.542.341.761.633.222.874.7110.935.02
000.642.472.752.923.234.154.635.098.497.35
2.693.633.372.171.542.943.483.9612.7117.5618.396.98
3.024.115.3214.3411.3511.7712.1330.440.5460.1775.8742.82
9.119.7728.4833.3717.0418.4423.4443.765.8887.0693.4987.15
                       
101010101010101010101014.78
0.991.5521.4235.2736.437.2338.1939.4541.3543.945.5647.5
-2.14-1.98-5.01-13.81-28.98-36-37.38-33.64-20.09-12.78-12.15-21.91
000000000000
000000000000
-1.14-0.4216.4221.477.431.240.825.8221.2731.1333.4225.61
0.10.231.1821.051.071.251.531.561.712.971.63
0.070.130.711.871.050.952.35.376.4610.338.49.21
3.263.232.293.173.433.265.626.647.639.3511.8322.72
000000000000
0000.450.330.11.10.022.80.050.020.03
3.433.594.187.495.865.3810.2713.5618.4521.4423.2233.57
0000.130100.032.132.092.062.04
000012014080900000
6.87.48.675.074.1410.7712.3524.2924.1633.2335.6226.77
6.87.48.675.24.2611.9112.4324.4126.2935.3237.6828.8
10.2310.9912.8512.6910.1217.2922.737.9744.7456.7660.962.38
9.0910.5729.2734.1617.5518.5323.5243.7966.0187.8994.3287.99
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Joint provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Joint's financial health and stability.

Assets

Joint's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Joint must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Joint after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Joint's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201220132014201520162017201820192020202120222023
00-3-8-15-3031370-9
000122112368
00100000-8-1010
3001-20212300
000051111225
000000000000
000000000000
200-6-100571113814
000-4-10-1-3-3-6-5-4
00-2-10-20-1-7-4-12-17-6
00-1-5-100-3-1-5-12-1
000000000000
0000000-14-200
00221400000000
00191201005-200
---2.00-1.00--------
000000000000
2017-4-13040120-98
2.050.18-1.1-10.87-12.42-0.524.344.048.026.852.319.68
000000000000

Joint stock margins

The Joint margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Joint. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Joint.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Joint's sales revenue. A higher gross margin percentage indicates that the Joint retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Joint's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Joint's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Joint's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Joint. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Joint's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Joint Margin History

Joint Gross marginJoint Profit marginJoint EBIT marginJoint Profit margin
2026e91.04 %14.19 %10.32 %
2025e91.04 %5.57 %4.31 %
2024e91.04 %-4.4 %-4.7 %
202391.04 %0.48 %-8.29 %
202290.92 %1.18 %0.59 %
202190.38 %7.63 %9.5 %
202088.93 %9.2 %22.49 %
201988.45 %7.22 %6.8 %
201888.28 %2.18 %0.27 %
201787.15 %-11.65 %-13.65 %
201685.85 %-56.1 %-74.15 %
201579.71 %-68.12 %-63.77 %
201467.61 %-22.54 %-42.25 %
201366.67 %6.67 %3.33 %
201260.71 %-46.43 %-25 %

Joint Stock Sales Revenue, EBIT, Earnings per Share

The Joint earnings per share therefore indicates how much revenue Joint has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Joint earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Joint's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Joint’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Joint's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Joint Revenue, EBIT and net profit per share

DateJoint Sales per ShareJoint EBIT per shareJoint Earnings per Share
2026e5.93 undefined0 undefined0.61 undefined
2025e7.06 undefined0 undefined0.3 undefined
2024e8.11 undefined0 undefined-0.38 undefined
20238.01 undefined0.04 undefined-0.66 undefined
20226.8 undefined0.08 undefined0.04 undefined
20215.37 undefined0.41 undefined0.51 undefined
20204.02 undefined0.37 undefined0.9 undefined
20193.34 undefined0.24 undefined0.23 undefined
20182.62 undefined0.06 undefined0.01 undefined
20171.89 undefined-0.22 undefined-0.26 undefined
20161.61 undefined-0.91 undefined-1.2 undefined
20151.38 undefined-0.94 undefined-0.88 undefined
20141.29 undefined-0.29 undefined-0.55 undefined
20130.65 undefined0.04 undefined0.02 undefined
20120.3 undefined-0.14 undefined-0.08 undefined

Joint business model

The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.com.

Joint SWOT Analysis

Strengths

Joint Corp possesses several strengths that contribute to its competitive advantage in the market:

  • Strong brand recognition and reputation in the industry
  • Wide network of clinics and licensed chiropractors
  • Effective marketing strategies to attract and retain clients
  • Proprietary technology and software for streamlined operations
  • Dedicated and experienced management team

Weaknesses

Despite its strengths, Joint Corp also faces certain weaknesses that can hinder its growth and performance:

  • Dependence on third-party payers for a significant portion of revenue
  • Limited international presence and potential growth opportunities
  • Reliance on a single service offering (chiropractic care)
  • Higher costs of operations compared to some competitors
  • Vulnerability to changes in healthcare policies and regulations

Opportunities

Joint Corp can leverage several opportunities in the market to further enhance its position:

  • Growing demand for non-invasive and drug-free healthcare alternatives
  • Expansion into new geographic markets with underserved populations
  • Development of strategic partnerships with insurance providers
  • Integration of complementary wellness services to diversify offerings
  • Utilization of telehealth technology for remote consultations

Threats

Several threats exist that could negatively impact Joint Corp's business and market position:

  • Intense competition from both traditional healthcare providers and other alternative therapies
  • Economic downturns and fluctuations affecting consumer spending on healthcare
  • Increased regulatory scrutiny and potential legal challenges
  • Negative public perception or misconceptions about chiropractic care
  • Technological advancements enabling self-treatment options or substitutes

Joint Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Joint Revenue by Segment

Segmente202220212020201820172016
Revenues from company-owned or managed clinics------
Royalty fees------
Franchise------
Advertising fund revenue------
Software/IT------
Regional developer fees------
Other revenues------

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Joint Revenue by Segment

Segmente202220212020201820172016
Corporate clinics59.42 M USD44.35 M USD31.77 M USD---
Franchise operations42.49 M USD36.51 M USD26.91 M USD---
Franchise Operations---17.12 M USD14.04 M USD11.97 M USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Joint Revenue by Segment

Segmente202220212020201820172016
Corporate Clinics---14.67 M USD11.13 M USD8.55 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Joint Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Joint historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Joint shares outstanding

The number of shares was Joint in 2024 — This indicates how many shares 14.688 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Joint earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Joint's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Joint’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Joint's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Joint.

Joint latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.01 -0.21  (-2,660.98 %)2024 Q3
6/30/2024-0.02 -0.13  (-614.29 %)2024 Q2
3/31/2024-0.01 0.06  (1,083.61 %)2024 Q1
12/31/20230.01 -0.75  (-6,247.54 %)2023 Q4
9/30/20230.02 -0.05  (-371.74 %)2023 Q3
6/30/20230.01 -0.01  (-198.04 %)2023 Q2
3/31/2023-0.01 0.15  (2,559.02 %)2023 Q1
12/31/20220.08 0.04  (-47.71 %)2022 Q4
9/30/20220.06 0.03  (-46.52 %)2022 Q3
6/30/20220.01 0.02  (47.06 %)2022 Q2
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Joint stock

Eulerpool World ESG Rating (EESG©)

56/ 100

🌱 Environment

64

👫 Social

35

🏛️ Governance

69

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Joint shareholders

%
Name
Stocks
Change
Date
26.28368 % Bandera Partners LLC3,937,29606/30/2024
6.70414 % The Vanguard Group, Inc.1,004,280-19,4326/30/2024
4.99026 % BlackRock Institutional Trust Company, N.A.747,541-122,1366/30/2024
4.22366 % Skylands Capital, LLC632,705-56,3256/30/2024
2.63336 % Renaissance Technologies LLC394,47820,4006/30/2024
1.95916 % Goldman Sachs Asset Management, L.P.293,4822,5266/30/2024
1.92678 % State Street Global Advisors (US)288,632-7,2516/30/2024
1.92615 % Geode Capital Management, L.L.C.288,538-27,4276/30/2024
1.82804 % D. E. Shaw & Co., L.P.273,840-15,5936/30/2024
1.39720 % First Foundation Advisors209,30106/30/2024
1
2
3
4
5
...
10

Joint Executives and Management Board

Mr. Peter Holt

(64)
Joint President, Chief Executive Officer, Director (since 2016)
Compensation 722,026

Mr. Jake Singleton

(41)
Joint Chief Financial Officer
Compensation 406,418

Mr. Matthew Rubel

(65)
Joint Lead Independent Director
Compensation 115,000

Mr. Ronald DaVella

(66)
Joint Independent Director
Compensation 115,000

Ms. Suzanne Decker

(61)
Joint Independent Director
Compensation 105,000
1
2
3

Most common questions regarding Joint

What values and corporate philosophy does Joint represent?

The Joint Corp is a dynamic and innovative company that focuses on revolutionizing the chiropractic care industry. With a commitment to improving the quality of life for their patients, the Joint Corp values convenience, affordability, and accessibility. Their corporate philosophy revolves around providing exceptional chiropractic services that are easily accessible to individuals from all walks of life. By offering affordable pricing and eliminating the need for insurance, the Joint Corp aims to make chiropractic care a staple in everyone's wellness routine. Their dedication to patient satisfaction, superior service, and positive outcomes sets them apart in the healthcare industry.

In which countries and regions is Joint primarily present?

Joint Corp is primarily present in the United States.

What significant milestones has the company Joint achieved?

Joint Corp, a leading company in the chiropractic care industry, has achieved several significant milestones in its journey. Over the years, Joint Corp has successfully expanded its network of chiropractic clinics across the United States, providing accessible and high-quality care to thousands of patients. The company also went public in 2014, increasing its financial stability and allowing for further growth and innovation. Joint Corp has been recognized for its exceptional franchise model, attracting talented chiropractors to join its team and contribute to its success. Through strategic partnerships and continuous advancements in technology, Joint Corp continues to solidify its position as a trusted and pioneering name in the chiropractic care market.

What is the history and background of the company Joint?

The Joint Corp, founded in 1999, is a leading chiropractic care company based in Scottsdale, Arizona. With a mission to improve the quality of life through chiropractic care, the company operates over 600 clinics across the United States. Joint Corp provides convenient, affordable, and accessible chiropractic services, focusing on subluxation correction and wellness care. Over the years, the company has developed a reputation for its patient-centered approach, fostering long-term relationships with clients. With a strong commitment to promoting the benefits of chiropractic care, Joint Corp continues to expand its presence and deliver high-quality healthcare services to individuals seeking natural pain relief and improved mobility.

Who are the main competitors of Joint in the market?

The main competitors of Joint Corp in the market include chiropractic clinics and wellness centers that offer similar services and treatments for musculoskeletal conditions. Some notable competitors include AmeriCare Physical Therapy, The Joint Chiropractic, and The Joint...the chiropractic place. These competitors, like Joint Corp, aim to provide quality chiropractic care and wellness solutions to their customers. However, Joint Corp stands out due to its unique business model of providing affordable and convenient chiropractic services through its nationwide network of franchised clinics.

In which industries is Joint primarily active?

Joint Corp is primarily active in the healthcare industry.

What is the business model of Joint?

The business model of Joint Corp primarily focuses on providing chiropractic care services. Joint Corp operates a network of chiropractic clinics across the United States, offering convenient and affordable access to chiropractic adjustments. Their model involves providing membership plans and walk-in options for individuals seeking chiropractic treatment for common health issues, including neck and back pain. Joint Corp's unique approach aims to offer standardized care through its proprietary software system, ensuring consistent treatment techniques across their clinics. By emphasizing a membership-based model, Joint Corp aims to create long-term relationships with their customers, enhancing accessibility and affordability for chiropractic care services.

What is the P/E ratio of Joint 2025?

The Joint P/E ratio is 36.74.

What is the P/S ratio of Joint 2025?

The Joint P/S ratio is 1.58.

What is the Quality Investing of Joint?

The Quality Investing for Joint is 3/10.

What is the revenue of Joint 2025?

The expected Joint revenue is 105.69 M USD.

How high is the profit of Joint 2025?

The expected Joint profit is 4.55 M USD.

What is the business model of Joint

The company Joint Corp is a company specializing in the healthcare industry. With over 520 locations in the USA, the company is a leading provider of chiropractic services. The business model of Joint Corp is based on providing chiropractic services. The company offers a wide range of services to help people relieve their pain and discomfort. The services mainly focus on improving the mobility and function of the neck, back, shoulders, and other areas of the body. Joint Corp also offers various products to help alleviate painful symptoms. These include things like special pillows and sleep masks that help people sleep better. In addition, Joint Corp also offers dietary supplements that are intended to improve overall body health. The company also uses various marketing strategies to attract customers. These include digital marketing campaigns and marketing on social media. Joint Corp also collaborates with third-party partners and ensures that the staff in customer contact is friendly and courteous. The company seems to be successful as it is experiencing steady growth and successfully offers its services. Joint Corp has various divisions. The main business division is chiropractic services. In addition, the company is also involved in the healthcare products sector. Joint Corp also has a range of wellness and health programs. These programs are designed to help customers improve their mobility and function and promote their overall health. Joint Corp is a company dedicated to providing chiropractic services. It uses various marketing strategies to attract customers and offers a wide range of products to help people with pain and discomfort. In addition, Joint Corp offers various wellness and health programs. In summary, Joint Corp is a company dedicated to improving the health and well-being of its customers.

What is the Joint dividend?

Joint pays a dividend of 0 USD distributed over payouts per year.

How often does Joint pay dividends?

The dividend cannot currently be calculated for Joint or the company does not pay out a dividend.

What is the Joint ISIN?

The ISIN of Joint is US47973J1025.

What is the Joint WKN?

The WKN of Joint is A12FCC.

What is the Joint ticker?

The ticker of Joint is JYNT.

How much dividend does Joint pay?

Over the past 12 months, Joint paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Joint is expected to pay a dividend of 0 USD.

What is the dividend yield of Joint?

The current dividend yield of Joint is .

When does Joint pay dividends?

Joint pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Joint?

Joint paid dividends every year for the past 0 years.

What is the dividend of Joint?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Joint located?

Joint is assigned to the 'Health' sector.

Wann musste ich die Aktien von Joint kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Joint from 2/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/9/2025.

When did Joint pay the last dividend?

The last dividend was paid out on 2/9/2025.

What was the dividend of Joint in the year 2024?

In the year 2024, Joint distributed 0 USD as dividends.

In which currency does Joint pay out the dividend?

The dividends of Joint are distributed in USD.

All fundamentals about Joint

Our stock analysis for Joint Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Joint Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.